phathompharma.com (PHAT): Company Cash on Hand

Official company branding of Phathom Pharmaceuticals (PHAT)

Phathom Pharmaceuticals (PHAT) price volatility is being smoothed by inert demand for GI therapy, which creates a stable cash flow. Business scalability through patents and the limited impact of geopolitics on the US market strengthen resilience. The free cash flow metric demonstrates liquidity dynamics, while the 0.18 value shows the company's current cash reserves for debt protection.

Company Total Cash Volume: Phathom Pharma (PHAT) for 07/04/2022 - 11/21/2026

Analytical breakdowns for Phathom Pharmaceuticals

- stock value and consensus price forecast:
Fundamental valuation:PHAT phathompharma.com
Brand item of Phathom Pharmaceuticals, Inc.

This indicator measures daily liquid asset volume, allowing for an assessment of the capital burn rate and the business's ability to service short-term liabilities without compromising operational stability. Analyzing the structure of cash balances helps determine whether reserves are sufficient for expansion into pharmacy retail via discount systems, despite the growing pricing power of Phathom Pharmaceuticals (PHAT) in the gastritis therapy segment.